1 8 BACKGROUND: Multiple sclerosis (MS) is an autoimmune disorder of the central 1 9 3 1 cells was studied by flow cytometry. The capacity of IgH[MOG] B cells to present 3 2 antigen to CD4 + T cells was assessed using in vitro priming assays with MOG [35-3 3 55] as the antigen.
Laboratories) intraperitoneally. Mice were monitored daily for signs of EAE, which 1 2 1 were assessed using a semi-quantitative 0-5 scale: 0; no disease, 0.5; ruffled fur, 1 2 2 1 3 2 the infiltration of immune cells, or Luxol fast blue (LFB) to detect demyelination. The images were taken at 10X and 20X magnifications with Nikon Eclipse 80i 1 3 4 microscope and were analysed using ImageJ software (NIH). Mice were euthanized and perfused intracardially with PBS. Brain and spinal cord 1 4 7 were dissected from the skull and vertebral column respectively and were 1 4 8 prepared as previously described [17] . Briefly, CNS tissues were digested with 1 4 9 liberase (Roche) and DNAse I (Sigma) and cells were enriched using a 35% 1 5 0 Percoll (GE Healthcare) gradient. The following monoclonal antibodies against mouse antigens were used: CD45, 1 7 0 clone A20 (Biolegend); CD11b, clone M1/70 (eBioscience); CD11c, clone N418 1 7 1 (Biolegend); Ly6G, clone 1A8 (BD Biosciences); CD4, clone RM4-5 1 7 2 (eBioscience); CD8, clone 53-6.7 (Biolegend); CD19, clone 1D3 (eBioscience); were cultured with B cells at a ratio of 1 CD4: 1 B, with 0, 1 or 10µg ml -1 MOG [35- For comparison of EAE scores on individual days, Mann-Whitney U test was 1 9 3 used. Fisher's exact test was used to measure the frequency of mice attaining 1 9 4 ethical endpoints. For immunoglobulin analyses and ex vivo cytokine profiling, unpaired Student t-tests were used. For cytokine production in the in vitro priming 1 9 6 experiment, two way ANOVA was used. Two-tailed analyses were used in all 1 9 7 instances. All statistical analyses were conducted using Prism software 1 9 8 (GraphPad). When immunized with MOG , wildtype (WT) NOD strain gradually We next wanted to examine whether there were differences between NOD We first sacrificed mice at the pre-onset stage (d5-post immunization) and We then assessed the frequency of immune cell proportions at disease cells, dendritic cells and neutrophils were also more prevalent in the CNS of Figure 4C ), though overall frequency of these cells were low in all 2 5 9 mice studied (<5%). The frequency of CD4 + T cells was also higher in the 2 6 0 13 spleens of IgH[MOG] mice at endpoint, suggesting their expansion in these 2 6 1 animals ( Figure 4D ). Interestingly, despite having an antigenic repertoire heavily 2 6 2 skewed towards MOG reactivity, immunized IgH[MOG] mice did not display an As we had observed an elevated frequency of CD4 + T cells in the CNS of Th1 signature cytokine IFN-γ in the CNS ( Figure 5A ). By contrast we saw a 2 7 7 striking upregulation of IL-17 production from CNS-infiltrating CD4 + T cells from 2 7 8 IgH[MOG] at disease endpoint ( Figure 5B) . Notably, production of GM-CSF, a 2 7 9 key pathogenic cytokine implicated in Th17-driven tissue inflammation, was also 2 8 0 augmented in IgH[MOG] CD4 + T cells ( Figure 5C ), though no differences were 2 8 1 noted in the production of TNFα ( Figure 5D ). In sum, our data showed that Th17 Thus far, we had found evidence of increased expansion and cytokine to MOG (Figure 6A ). However, IgH[MOG] B cells elicited a greater frequency 2 9 8 of CD4 + T cells that expressed IFN-γ, IL-17, and the autocrine T cell growth 2 9 9 factor IL-2 ( Figure 6B ). Altogether, our findings indicated that IgH[MOG] B cells The role of CD4 + T cells in the autoimmune pathogenesis of MS is well- severity than controls when immunized with the myelin-derived epitope 3 2 0 proteolipid protein (PLP) [139] [140] [141] [142] [143] [144] [145] [146] [147] [148] [149] [150] [151] [152] [153] [154] [14] , which induces a relapsing/remitting disease In our study, we actively immunized IgH[MOG] mice on NOD background with 3 2 6 the class II restricted peptide MOG . This permitted us to study the 3 2 7 contribution of MOG-reactive B cells in a model of EAE that is initiated by CD4 + T These findings indicated that the collaboration of both myelin-specific B and T which are associated with rapid acceleration of the disease. Here, our data 3 5 0 suggest that the inverse may also be true and that B cells may reinforce and 3 5 1 augment Th17-mediated pathogenicity in the CNS.
5 2
A key antibody independent function of B cells is the antigen presentation 3 5 3 to T cells, and B cells are particularly efficient at presenting their cognate antigen 3 5 4
[35]. Interestingly, we found that in the presence of MOG , IgH[MOG] B cells 3 5 5 were better able than WT B cells to induce the production of inflammatory 3 5 6 cytokines from MOG -reactive CD4 + T cells. These findings are broadly in showed enhanced responses to MOG relative to splenocytes from 1C6 [24]. Notably, however, B-MHC-II -/mice develop EAE in response to MOG . IgH[MOG] mice, antigen presentation of MOG itself by B cells may mice were immunized with MOG , sacrificed at d5, and CNS (A) and Splenic immunized with MOG and sacrificed at d14. CNS-infiltrating (C) and splenic p<0.0001, t-test n.s., not significant. immunized with MOG and sacrificed at disease endpoints. Production of CellTrace Violet-labeled CD4 + T cells from male 1C6 mice, and with 0,1 or 5. Owens GP, Kraus H, Burgoon MP, Smith-Jensen T, Devlin ME, Gilden DH.
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Restricted use of VH4 germline segments in an acute multiple sclerosis brain. 
